These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16432549)

  • 21. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects.
    Vidgren HM; Agren JJ; Valve RS; Karhunen LJ; Rissanen AM; Uusitupa MI
    Clin Pharmacol Ther; 1999 Sep; 66(3):315-22. PubMed ID: 10511068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity.
    Guven GS; Kiliçaslan A; Oz SG; Haznedaroglu IC; Kirazli S; Aslan D; Sözen T
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):364-8. PubMed ID: 16959692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives.
    Karatela RA; Sainani GS
    Indian Heart J; 2009; 61(2):156-9. PubMed ID: 20039500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine, folic acid and vitamin B12 concentration in patients with recurrent miscarriages.
    Sikora J; Magnucki J; Zietek J; Kobielska L; Partyka R; Kokocinska D; Białas A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):507-12. PubMed ID: 17693963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients.
    Cakmak SK; Gül U; Kiliç C; Gönül M; Soylu S; Kiliç A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):300-3. PubMed ID: 19207655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An RCT of metformin versus orlistat for the management of obese anovulatory women.
    Metwally M; Amer S; Li TC; Ledger WL
    Hum Reprod; 2009 Apr; 24(4):966-75. PubMed ID: 19095663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease.
    Cook SA; MacLaughlin H; Macdougall IC
    Nephrol Dial Transplant; 2008 Jan; 23(1):263-8. PubMed ID: 17977872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obese children and adolescents: a risk group for low vitamin B12 concentration.
    Pinhas-Hamiel O; Doron-Panush N; Reichman B; Nitzan-Kaluski D; Shalitin S; Geva-Lerner L
    Arch Pediatr Adolesc Med; 2006 Sep; 160(9):933-6. PubMed ID: 16953016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of the mass-reductive therapy with orlistat on 25-(OH)-D3 and PTH concentration in sera of obese, menopausal women].
    Holecki M; Zahorska-Markiewicz B; Nieszporek T; Olszanecka-Glinianowicz M; Mizia-Stec K; Zak-Gołab A; Kocełak P; Fryźlewicz-Moska A; Wiecek A
    Endokrynol Pol; 2005; 56(3):240-5. PubMed ID: 16350716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
    Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
    Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of body weight and co-morbidities by orlistat: The XXL--Primary Health Care Trial.
    Wirth A
    Diabetes Obes Metab; 2005 Jan; 7(1):21-7. PubMed ID: 15642072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute effect of orlistat on endothelial function in young obese women.
    Sekuri C; Tavli T; Avsar A; Sozcuer H; Uyanik BS; Ari Z
    Int J Clin Pharmacol Res; 2003; 23(4):111-7. PubMed ID: 15224500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of weight loss on P wave dispersion in obese subjects.
    Duru M; Seyfeli E; Kuvandik G; Kaya H; Yalcin F
    Obesity (Silver Spring); 2006 Aug; 14(8):1378-82. PubMed ID: 16988080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The levels of vitamins A, E, B12 and folic acid in noise-induced hearing loss].
    Gök U; Halifeoğlu I; Yildiz M
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):60-4. PubMed ID: 16010102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.